MIBC comprises about 20% of bladder cancer cases and is known to have mutations in tumor suppressor TP53, FGFR3, transcriptional activator ELF3, histone demethylase KDM6A, tumor suppressor RB1, and DNA helicase ERCC2 [11]. Here, FGFR3 is linked to urinary bladder cancer.